Boston Scientific Lowers Annual Forecast, Shares Rise After Reset

Although Boston Scientific’s revised annual earnings forecast is a negative development, the stock gained 1% following the reset. Technical indicators support a short‑term upward trend: the price remains above the 20‑ and 50‑day moving averages, the MACD has crossed above its signal line, and the RSI sits around 63. With the RSI still below 70, the stock has not entered an overbought zone. Consequently, a modest price increase over the next one to three days is expected. However, the long‑term implications of the downgraded forecast should be taken into account.

Boston Scientific's downgrade may be interpreted as a correction signal within the sector, but no direct impact is expected for a technology giant like GOOGL. Since the shares rallied after the reset, there is a slight short‑term optimism across the market. GOOGL's technical indicators (RSI 59, positive MACD, SMA20 and SMA50 close) support the continuation of the trend. Therefore, the price is likely to fluctuate around current levels over a 1‑3 day period. Overall, the impact of this news on GOOGL will remain limited.